Dr. Modarressi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
21 Route 31 N
Ste B6
Pennington, NJ 08534Phone+1 609-951-3944Fax+1 609-955-3078
Education & Training
University of Pennsylvania Health SystemFellowship, Endocrinology, Diabetes, and Metabolism, 2016 - 2018
Massachusetts General HospitalResidency, Internal Medicine, 2013 - 2016
New York University School of MedicineClass of 2013, Alpha Omega Alpha
Princeton UniversityMolecular Biology, 2005 - 2009
Certifications & Licensure
NJ State Medical License 2018 - 2025
PA State Medical License 2016 - 2018
MA State Medical License 2013 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- American Board of Obesity Medicine Obesity Medicine
Publications & Presentations
PubMed
- Role and impact of a specialized cardiometabolic clinic in managing high-risk patients with type 2 diabetes and atherosclerotic cardiovascular disease.Taher Modarressi
American Journal of Preventive Cardiology. 2024-09-01 - Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease?Taher Modarressi
Cleveland Clinic Journal of Medicine. 2024-02-02 - Letter to the Editor From Modarressi and Derakhshan: "Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Tri...Taher Modarressi, Arsalan Derakhshan
The Journal of Clinical Endocrinology and Metabolism. 2023-07-14
Press Mentions
Insurers Clamping Down on Doctors Who Prescribe Ozempic for Weight LossJune 13th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
